Computer-aided design of selective COX-2 inhibitors: Comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives

被引:58
作者
Desiraju, GR [1 ]
Gopalakrishnan, B
Jetti, RKR
Nagaraju, A
Raveendra, D
Sarma, JARP
Sobhia, ME
Thilagavathi, R
机构
[1] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India
[2] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, SAS Nagar 160062, India
[3] Indian Inst Chem Technol, Organ Div 1, Mol Modeling Grp, Hyderabad 500007, Andhra Pradesh, India
[4] Guk BioSci Put Ltd, Hyderabad 500016, Andhra Pradesh, India
关键词
D O I
10.1021/jm020198t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Comparative molecular field analysis and comparative molecular similarity indices analysis were performed on 114 analogues of 1,2-diarylimidazole to optimize their cyclooxygenase-2 (COX-2) selective antiinflammatory activities. These studies produced models with high correlation coefficients and good predictive abilities. Docking studies were also carried out wherein these analogues were docked into the active sites of both COX-1 and COX-2 to analyze the receptor ligand interactions that confer selectivity for COX-2. The most active molecule in the series (53) adopts an orientation similar to that of SC-558 (4-[5-(4-bromophenyl)-3-trifluoromethyl-1H-1-pyrozolyl]-1-benzenesulfonamide) inside the COX-2 active site while the least active molecule (101) optimizes in a different orientation. In the active site, there are some strong hydrogen-bonding interactions observed between residues His90, Arg513, and Phe518 and the ligands. Additionally, a correlation of the quantitative structure-activity relationship data and the docking results is found to validate each other and suggests the importance of the binding step in overall drug action.
引用
收藏
页码:4847 / 4857
页数:11
相关论文
共 45 条
[1]  
ABOLA EE, 1987, PROTEIN DATA BANK CR, P171
[2]   Structure-based design of COX-2 selectivity into flurbiprofen [J].
Bayly, CI ;
Black, WC ;
Léger, S ;
Ouimet, N ;
Ouellet, M ;
Percival, MD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) :307-312
[3]   Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: A comparative molecular field analysis [J].
Chavatte, P ;
Yous, S ;
Marot, C ;
Baurin, N ;
Lesieur, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (20) :3223-3230
[4]  
Clark M., 1990, TETRAHEDRON COMPUT M, V3, P47, DOI DOI 10.1016/0898-5529(90)90120-W
[5]   Three-dimensional quantitative structural activity relationship (3D-QSAR) studies of some 1,5-diarylpyrazoles: Analogue based design of selective cyclooxygenase-2 inhibitors [J].
Desiraju, GR ;
Gopalakrishnan, B ;
Jetti, RKR ;
Raveendra, D ;
Sarma, JARP ;
Subramanya, HS .
MOLECULES, 2000, 5 (07) :945-955
[6]   Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis and docking studies of some 3,4-diaryloxazolone derivatives [J].
Desiraju, GR ;
Sarma, JARP ;
Raveendra, D ;
Gopalakrishnan, B ;
Thilagavathi, R ;
Sobhia, ME ;
Subramanya, HS .
JOURNAL OF PHYSICAL ORGANIC CHEMISTRY, 2001, 14 (07) :481-487
[7]  
DeWitt DL, 1999, MOL PHARMACOL, V55, P625
[8]   2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors [J].
Dubé, D ;
Brideau, C ;
Deschênes, D ;
Fortin, R ;
Friesen, RW ;
Gordon, R ;
Girard, Y ;
Riendeau, D ;
Savoie, C ;
Chan, CC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (12) :1715-1720
[9]   Novel 1,2-diarylcyclobutenes: Selective and orally active COX-2 inhibitors [J].
Friesen, RW ;
Dube, D ;
Fortin, R ;
Frenette, R ;
Prescott, S ;
Cromlish, W ;
Greig, GM ;
Kargman, S ;
Wong, E ;
Chan, CC ;
Gordon, R ;
Xu, LJ ;
Riendeau, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (22) :2677-2682
[10]   EXPRESSION AND SELECTIVE-INHIBITION OF THE CONSTITUTIVE AND INDUCIBLE FORMS OF HUMAN CYCLOOXYGENASE [J].
GIERSE, JK ;
HAUSER, SD ;
CREELY, DP ;
KOBOLDT, C ;
RANGWALA, SH ;
ISAKSON, PC ;
SEIBERT, K .
BIOCHEMICAL JOURNAL, 1995, 305 :479-484